TG Therapeutics, Inc. (FRA:NKB2)
Germany
· Delayed Price · Currency is EUR 27.40
+1.38 (5.32%)
At close: Dec 4, 2025
-13.77% (1Y)
| Market Cap | 3.93B |
| Revenue (ttm) | 453.34M |
| Net Income (ttm) | 381.38M |
| Shares Out | n/a |
| EPS (ttm) | 2.37 |
| PE Ratio | 10.31 |
| Forward PE | 22.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 88 |
| Average Volume | 88 |
| Open | 26.77 |
| Previous Close | 26.02 |
| Day's Range | 26.77 - 27.40 |
| 52-Week Range | 22.47 - 39.98 |
| Beta | n/a |
| RSI | 48.12 |
| Earnings Date | Feb 27, 2026 |